Faculty Staff

Seet Ju Ee

BA (Hons), MB BCh, FRCPath (UK)
Doctor
Senior Consultant
Department of Pathology, NUH

Tel: +65 6772 2058
Email:

Clinical Interest

Lung and thoracic pathology
Cytopathology

Education

1993 – BA (Hons) First Class (Natural Sciences – Physiology), University of Cambridge, UK
1995 – MB BCh, University of Cambridge, UK
2002 – MRCPath (UK)
2003 – Certificate of Completion of Specialist Training and entry into the UK Specialist Register (Specialty: Histopathology)
2006 FRCPath (UK)

Professional / Clinical experience

2011 to present – Senior Consultant, Department of Pathology, National University Hospital, Singapore
2010 to present – Assistant Professor, Department of Pathology, National University of Singapore
2009 to 2011 – Consultant, Department of Pathology, National University Hospital, Singapore
2006 to 2009 – Consultant, Department of Cellular Pathology, St George's Hospital, London, UK
2003 to 2006 – Consultant, Department of Histopathology, Princess Royal University Hospital, Orpington, Kent UK
1993 to 2003 – Specialist Registrar rotation in Histopathology, London, UK. Rotating through the following hospitals: West Middlesex University Hospital , Charing Cross Hospital, Hammersmith Hospital, Royal Marsden Hospital, St George's Hospital
1997 to 1998 – Senior House Officer, Department of Pathology, Ninewells Hospital, Dundee, UK

I use my skills in lung and thoracic pathology mainly in collaborative research.

Current collaborations:

Lung cancer (various collaborations with medical oncologists)
Interventional bronchoscopic techniques for diagnosis and staging of lung cancer and diagnosis and management of other respiratory conditions (collaboration with respiratory physicians)
Mouse influenza model (collaboration with Department of Microbiology, National University of Singapore)
1. Venkatesh SK, Wang G, Seet JE, Teo LL, Chong VF.
MRI for transformation of preserved organs and their pathologies into digital formats for medical education and creation of a virtual pathology museum. A pilot study. Clin Radiol. 2013 Mar;68(3):e114-22. doi: 10.1016/j.crad.2012.10.009. Epub 2012 Dec 12. PMID: 23246024
2. Pang B, Dettmer M, Ong CW, Dhewar AN, Gupta S, Lim GL, Nga ME, Seet JE, Qasim A, Chin TM, Soo R, Soong R, Salto-Tellez M.
The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases. Cytopathology. 2012 Aug;23(4):229-36. doi: 10.1111/j.1365-2303.2012.01000.x. Erratum in: Cytopathology. 2012 Dec;23(6):422. Matthias, D [corrected to Dettmer, M]. PMID: 22805513
3. Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, Teo AS, Ariyaratne PN, Takahashi N, Sawada K, Fei Y, Soh S, Lee WH, Huang JW, Allen JC Jr, Woo XY, Nagarajan N, Kumar V, Thalamuthu A, Poh WT, Ang AL, Mya HT, How GF, Yang LY, Koh LP, Chowbay B, Chang CT, Nadarajan VS, Chng WJ, Than H, Lim LC, Goh YT, Zhang S, Poh D, Tan P, Seet JE, Ang MK, Chau NM, Ng QS, Tan DS, Soda M, Isobe K, Nöthen MM, Wong TY, Shahab A, Ruan X, Cacheux-Rataboul V, Sung WK, Tan EH, Yatabe Y, Mano H, Soo RA, Chin TM, Lim WT, Ruan Y, Ong ST.
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nat Med. 2012 Mar 18;18(4):521-8. doi: 10.1038/nm.2713. PMID:22426421
4. Ng HH, Narasaraju T, Phoon MC, Sim MK, Seet JE, Chow VT.
Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp Mol Pathol. 2012 Jun;92(3):287-95. doi: 10.1016/j.yexmp.2012.03.003. Epub 2012 Mar 7. PMID: 22421441
5. In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection. J Gen Virol. 2012 Jun;93(Pt 6):1269-77. doi: 10.1099/vir.0.040824-0. Epub 2012 Feb 29. PMID: 22377585
6. Verghese ET, den Bakker MA, Campbell A, Hussein A, Nicholson AG, Rice A, Corrin B, Rassl D, Langman G, Monaghan H, Gosney J, Seet J, Kerr K, Suvarna SK, Burke M, Bishop P, Pomplun S, Willemsen S, Addis B.
Interobserver variation in the classification of thymic tumours––a multicentre study using the WHO classification system. Histopathology. 2008 Aug;53(2):218-23. doi: 10.1111/j.1365-2559.2008.03088.x. PMID: 18752504